Knight Therapeutics | GUD - Net Income



Knight Therapeutics reported CAD85K in Net Income for its fiscal quarter ending in September of 2024.


Net Income Change Date
Acasti Pharma USD -3360000 795K Jun/2025
Alaunos Therapeutics USD -742000 385K Dec/2024
Aurora Cannabis CAD -15210000 46.88M Jun/2025
Avita Medical AUD -11589000 3.8M Dec/2024
Canopy Growth CAD -41530000 80.37M Jun/2025
Cronos Group USD -39711000 45.83M Jun/2025
Dianthus Therapeutics USD -31629000 3.19M Jun/2025
Ionis Pharmaceuticals USD 123.55M 270.49M Jun/2025
IQVIA Holdings USD 266M 17M Jun/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Moderna USD -825000000 146M Jun/2025
Organigram Holdings CAD -6290000 16.67M Jun/2025
Organon & Co USD 145M 58M Jun/2025
Revvity USD 53.95M 11.71M Jun/2025
Tectonic Therapeutic USD -19980000 7.61M Jun/2025
Tilray USD -85342000 46.18M Nov/2024
Viatris USD -4600000 3.04B Jun/2025
Xeris Pharmaceuticals USD -1930000 52.91M Jun/2025